首页> 外文期刊>Organic letters >Mollemycin A: An Antimalarial and Antibacterial Glycohexadepsipeptide- polyketide from an Australian Marine-Derived Streptomyces sp. (CMB-M0244)
【24h】

Mollemycin A: An Antimalarial and Antibacterial Glycohexadepsipeptide- polyketide from an Australian Marine-Derived Streptomyces sp. (CMB-M0244)

机译:Mollemycin A:来自澳大利亚海洋衍生的链霉菌属sp的抗疟和抗菌糖基己糖肽-聚酮化合物。 (CMB-M0244)

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A marine-derived Streptomyces sp. (CMBM0244) isolated from a sediment collected off South Molle Island, Queensland, produced mollemycin A (1) as a new first in class glyco-hexadepsipeptide-polyketide. The structure of 1 was assigned by detailed spectroscopic analysis, supported by chemical derivatization and degradation, and C_3 Marfey’s analysis. Mollemycin A (1) exhibits exceptionally potent and selective growth inhibitory activity against Gram-positive and Gram-negative bacteria (IC_(50) 10?50 nM) and drug-sensitive (3D7; IC_(50) 7 nM) and multidrug-resistant (Dd2; IC_(50) 9 nM) clones of the malaria parasite Plasmodium falciparum.
机译:海洋来源的链霉菌(CMBM0244)从昆士兰州南莫勒岛(South Molle Island)收集的沉积物中分离出,产生了莫勒霉素A(1),它是新型的首个糖-六肽肽-聚酮化合物。 1的结构是通过详细的光谱分析,化学衍生化和降解以及C_3 Marfey的分析确定的。莫勒霉素A(1)对革兰氏阳性和革兰氏阴性细菌(IC_(50)10?50 nM)和药物敏感(3D7; IC_(50)7 nM)和多重耐药性表现出异常有效的选择性生长抑制活性(Dd2; IC_(50)9 nM)疟原虫恶性疟原虫的克隆。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号